FDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia13 July 2011/in 2011, NewsFDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2011-07-13 14:34:122026-09-21 14:10:37FDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia
